![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
Alphabet Earnings Beat Wall Street Views: Build Your Growth Stock Watchlist With These Just Updated Screens
On Wednesday, Intra-Cellular Therapies (ITCI) got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 84. ↑ X NOW PLAYING Market Breadth: How This Indicator Reveals Hidden Weakness In A Bull Market IBD's proprietary RS Rating …